$18.03
-0.85-4.50%
At close: -
$18.03
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Spyre Therapeutics (SYRE) Forecast
NewsEarningsSpyre Therapeutics (SYRE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Spyre Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SYRE | Benzinga
Explore Spyre Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SYRE.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Spyre Therapeutics (SYRE) stock?
You can purchase shares of Spyre Therapeutics (NASDAQ:SYRE) through any online brokerage.
Who are Spyre Therapeutics (SYRE) competitors?
Other companies in Spyre Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX) and Replimune Group (NASDAQ:REPL).
What is the forecast, or price target, for Spyre Therapeutics (SYRE) stock?
Spyre Therapeutics has a consensus price target of $48.00.
What is the current price for Spyre Therapeutics (SYRE)?
The stock price for Spyre Therapeutics (NASDAQ: SYRE) is $18.03 last updated March 13, 2025 at 4:00 PM EDT.
Does Spyre Therapeutics (SYRE) pay a dividend?
There are no upcoming dividends for Spyre Therapeutics.
When is Spyre Therapeutics (NASDAQ:SYRE) reporting earnings?
Spyre Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Spyre Therapeutics (SYRE) going to split?
There is no upcoming split for Spyre Therapeutics.
What sector and industry does Spyre Therapeutics (SYRE) operate in?
Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.